|
Showing 1 - 3 of
3 matches in All Departments
Martin Nowak, one of the world's experts on evolution and game
theory, working here with bestselling science writer Roger
Highfield, turns an important aspect of evolutionary theory on its
head to explain why cooperation, not competition, has always been
the key to the evolution of complexity. In his first book written
for a wide audience, this hugely influential scientist explains his
cutting-edge research into the mysteries of cooperation, from the
rise of multicellular life to Good Samaritans, and from cancer
treatment to the success of large companies. With wit and clarity,
and an eye to its huge implications, Nowak and Highfield make the
case that cooperation, not competition, is the defining human
trait. "SuperCooperators "will expand our understanding of
evolution and provoke debate for years to come.
Beyond The Survival of the Fittest: Why Cooperation, not
Competition, is the Key to Life If life is about survival of the
fittest, then why would we risk our own life to jump into a river
to save a stranger? Some people argue that issues such as charity,
fairness, forgiveness and cooperation are evolutionary loose ends,
side issues that are of little consequence. But as Harvard's
celebrated evolutionary biologist Martin Nowak explains in this
groundbreaking and controversial book, cooperation is central to
the four-billion-year-old puzzle of life. Indeed, it is cooperation
not competition that is the defining human trait.
This groundbreaking book describes the emerging field of theoretical immunology, in particular the use of mathematical models to describe the spread of infectious diseases within patients. It reveals fascinating insights into the dynamics of viral and other infections, and the interactions between infectious agents and immune responses. Structured around the examples of HIV/AIDS and hepatitis B, Nowak and May show how mathematical models can help researchers to understand the detailed dynamics of infection and the effects of antiviral therapy. Models are developed to describe the dynamics of drug resistance, immune responses, viral evolution and mutation, and to optimise the design of therapy and vaccines.
|
|